{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:11:03Z","timestamp":1793214663840,"version":"4.5.0"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:p>Human papillomavirus (HPV)-independent primary endometrial squamous cell carcinoma (PESCC) is a rare but aggressive subtype of endometrial carcinoma for which little is known about the genomic characteristics. Traditional criteria have restricted the diagnosis of PESCC to cases without any cervical involvement. However, given that modern ancillary techniques can detect HPV and characteristic genetic alterations that should identify the more common mimics in the differential diagnosis, including endometrial endometrioid carcinoma with extensive squamous differentiation and HPV-associated primary cervical squamous cell carcinoma, those criteria may benefit from revision. To further characterize PESCC, we identified 5 cases of pure squamous cell carcinoma dominantly involving the endometrium that had the potential to be PESCC: 1 case involving only the endometrium and 4 cases with some involvement of the cervix. Clinicopathologic features were assessed and immunohistochemical analysis (p16, estrogen receptor, progesterone receptor, and p53), HPV RNA in situ hybridization (high-risk and low-risk cocktails and targeted probes for 16 and 18), and molecular studies were performed. All tumors showed aberrant\/mutation-type p53 expression, were negative for estrogen receptor, progesterone receptor, and p16, and had no detectable HPV. Per whole-exome sequencing, 4 of the 5 tumors demonstrated comutations in <jats:italic toggle=\"yes\">TP53<\/jats:italic> and <jats:italic toggle=\"yes\">CDKN2A<\/jats:italic> (p16). Four patients died of disease within 20 months (range, 1 to 20\u00a0mo; mean, 9\u00a0mo), and 1 patient had no evidence of disease at 38 months. PESCC represents a unique, clinically aggressive subtype of endometrial cancer with <jats:italic toggle=\"yes\">TP53<\/jats:italic> and <jats:italic toggle=\"yes\">CDKN2A<\/jats:italic> comutations. This characteristic profile, which is similar to HPV-independent squamous cell carcinoma of the vulva, is distinct from endometrioid carcinoma with extensive squamous differentiation and HPV-associated primary cervical squamous cell carcinoma and can be used to distinguish PESCC from those mimics even when cervical involvement is present. Diagnostic criteria for PESCC should be relaxed to allow for cervical involvement when other pathologic features are consistent with, and ancillary techniques are supportive of classification as such.<\/jats:p>","DOI":"10.1097\/pas.0000000000001970","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T16:07:18Z","timestamp":1662566838000},"page":"1611-1622","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["Molecular Analysis of HPV-independent Primary Endometrial Squamous Cell Carcinoma Reveals TP53 and CDKN2A Comutations"],"prefix":"10.1097","volume":"46","author":[{"given":"Mark R.","family":"Hopkins","sequence":"first","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen N.","family":"Palsgrove","sequence":"additional","affiliation":[{"name":"Department of Pathology, UT Southwestern Medical Center, Dallas, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte M.","family":"Ronnett","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Vang","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Lin","sequence":"additional","affiliation":[{"name":"Gynecology and Obstetrics, the Johns Hopkins Medical Institutions, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tricia A.","family":"Murdock","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"issue":"suppl 1","key":"R1-20250608","first-page":"S105","article-title":"Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer","volume":"95","author":"Creasman","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"R2-20250608","first-page":"1","article-title":"Uber die von Oberflachenepithel ausgehenden Carcinomformen des Uteruskorpes sowie Uber den Hornkrebs des Cavum uteri (About from the surface epithelium arising carcinoma types of the uterine corpus and about the keratinizing cancer of the uterine cavity)","volume":"24","author":"Gebhard","year":"1892","journal-title":"Z Geburtsh Gynakol"},{"key":"R3-20250608","first-page":"309","article-title":"Squamous epithelium in the endometrium in benign and malignant conditions","volume":"46","author":"Fluhmann","year":"1928","journal-title":"Surg Gynecol Obstet"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/dc.22814","article-title":"Primary squamous cell carcinoma of the endometrium: two cases and a review of the literature","volume":"41","author":"Goodrich","year":"2013","journal-title":"Diagn Cytopathol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.anndiagpath.2005.09.001","article-title":"p16, p14, p53, cyclin D1, and steroid hormone receptor expression and human papillomaviruses analysis in primary squamous cell carcinoma of the endometrium","volume":"10","author":"Horn","year":"2006","journal-title":"Ann Diagn Pathol"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1006\/gyno.1996.4597","article-title":"Squamous cell carcinoma of the endometrium with human papillomavirus type 31 and without tumor suppressor gene p53 mutation","volume":"65","author":"Kataoka","year":"1997","journal-title":"Gynecol Oncol"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ygyno.2004.11.019","article-title":"Primary squamous cell carcinoma of the endometrium: a case report with immunohistochemical and molecular study","volume":"96","author":"Giordano","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/PGP.0b013e3182936503","article-title":"Verrucous carcinoma of the endometrium: a rare and challenging diagnosis","volume":"33","author":"Stockinger","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1177\/0300060518776579","article-title":"Primary squamous cell carcinoma of the endometrium in a woman of reproductive age: a rare case report","volume":"46","author":"Wu","year":"2018","journal-title":"J Int Med Res"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"492","DOI":"10.15406\/ogij.2018.09.00393","article-title":"Primary squamous cell carcinoma of endometrium\u2014a rare presentation","volume":"9","author":"Akhtar","year":"2018","journal-title":"Obstet Gynecol Int J"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"1","DOI":"10.24966\/CSMC-8801\/100094","article-title":"Primary squamous cell carcinoma of the endometrium in a postmenopausal woman: case report","volume":"5","author":"Vadehra","year":"2020","journal-title":"J Clin Stud Med Case Rep"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4132\/KoreanJPathol.2013.47.6.549","article-title":"Primary squamous cell carcinoma of the upper genital tract: utility of p16INK4a expression and HPV DNA status in its differential diagnosis from extended cervical squamous cell carcinoma","volume":"47","author":"Yoo","year":"2013","journal-title":"Korean J Pathol"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4132\/KoreanJPathol.2012.46.4.395","article-title":"Primary endometrial squamous cell carcinoma: a case report and review of relevant literature on Korean women","volume":"46","author":"Lee","year":"2012","journal-title":"Korean J Pathol"},{"key":"R14-20250608","first-page":"350","article-title":"Primary squamous cell carcinoma of the endometrium: a case report","volume":"32","author":"Bifulco","year":"2011","journal-title":"Eur J Gynaecol Oncol"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/PGP.0b013e3181e2fe70","article-title":"p16 expression in squamous and trophoblastic lesions of the upper female genital tract","volume":"29","author":"Chew","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1006\/gyno.1995.1084","article-title":"Report of three new cases of squamous carcinoma of the endometrium with emphasis in the HPV status","volume":"56","author":"Im","year":"1995","journal-title":"Gynecol Oncol"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/PGP.0b013e31828cb0be","article-title":"Primary squamous cell carcinoma of the endometrium: clinicopathologic and molecular characteristics","volume":"32","author":"Bures","year":"2013","journal-title":"Int J Gynecol Pathol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/PGP.0000000000000820","article-title":"PAX8 positivity, abnormal p53 expression, and p16 negativity in a primary endometrial squamous cell carcinoma: a case report and review of the literature","volume":"41","author":"Fanni","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/gyno.1996.0096","article-title":"Squamous cell carcinoma of the endometrium: a report of eight cases and a review of the literature","volume":"61","author":"Goodman","year":"1996","journal-title":"Gynecol Oncol"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1746-1596-3-4","article-title":"Does \u201cichthyosis uteri\u201d have malignant potential?\u202f A case report of squamous cell carcinoma of endometrium associated with extensive ichthyosis uteri","volume":"3","author":"Murhekar","year":"2008","journal-title":"Diagn Pathol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12253-013-9607-3","article-title":"Primary squamous cell carcinoma of the endometrium unrelated to human papilloma virus: a molecular study","volume":"19","author":"Giordano","year":"2013","journal-title":"Pathol Oncol Res"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1097\/PGP.0000000000000488","article-title":"Interpretation of p53 immunohistochemistry in endometrial carcinomas: toward increased reproducibility","volume":"38","author":"K\u00f6bel","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/path.5375","article-title":"p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies","volume":"250","author":"Singh","year":"2020","journal-title":"J Pathol"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/his.14238","article-title":"Comparison of p53 immunohistochemical staining in differentiated vulvar intraepithelial neoplasia (dVIN) with that in inflammatory dermatoses and benign squamous lesions in the vulva","volume":"78","author":"Liu","year":"2021","journal-title":"Histopathology"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.oraloncology.2016.02.008","article-title":"RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization","volume":"55","author":"Rooper","year":"2016","journal-title":"Oral Oncol"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0046-8177(98)90197-6","article-title":"Comparison of estrogen and progesterone receptor, Ki-67, and p53 immunoreactivity in uterine endometrioid carcinoma and endometrioid carcinoma with squamous, mucinous, secretory, and ciliated cell differentiation","volume":"29","author":"Lax","year":"1998","journal-title":"Hum Pathol"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF01606889","article-title":"Immunohistochemical analysis of p53 protein over-expression in endometrial carcinomas: inverse correlation with sex steroid receptor status","volume":"423","author":"Koshiyama","year":"1993","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/modpathol.3800620","article-title":"Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis","volume":"19","author":"Reid-Nicholson","year":"2006","journal-title":"Mod Pathol"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00004347-200010000-00006","article-title":"Cyclin D1 expression in high-grade endometrial carcinomas\u2014association with histologic subtype","volume":"19","author":"Soslow","year":"2000","journal-title":"Int J Gynecol Pathol"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1097\/00000478-200412000-00004","article-title":"Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases","volume":"28","author":"Darvishian","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/00000478-200208000-00004","article-title":"Hormone receptor immunohistochemistry and human papillomavirus in situ hybridization are useful for distinguishing endocervical and endometrial adenocarcinomas","volume":"26","author":"Staebler","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/modpathol.3800950","article-title":"Identification of prognostically relevant and reproducible subsets of endometrial adenocarcinoma based on clustering analysis of immunostaining data","volume":"20","author":"Alkushi","year":"2007","journal-title":"Mod Pathol"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/PAS.0b013e3181971fdd","article-title":"Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor","volume":"33","author":"Yemelyanova","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.PGP.0000055172.04957.2F","article-title":"p16 immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinoma","volume":"22","author":"McCluggage","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/PGP.0b013e318177eadc","article-title":"Immunohistochemical differences between mucinous and microglandular adenocarcinomas of the endometrium and benign endocervical epithelium","volume":"27","author":"Chekmareva","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"R36-20250608","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/PAS.0000000000001598","article-title":"Molecularly classified uterine FIGO grade 3 endometrioid carcinomas show distinctive clinical outcomes but overlapping morphologic features","volume":"45","author":"Joehlin-Price","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R37-20250608","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<814::AID-CNCR12>3.0.CO;2-U","article-title":"The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways","volume":"88","author":"Lax","year":"2000","journal-title":"Cancer"},{"key":"R38-20250608","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/PGP.0000000000000162","article-title":"Endometrial Carcinomas With Clear Cells: A Study of a Heterogeneous Group of Tumors Including Interobserver Variability, Mutation Analysis, and Immunohistochemistry With HNF-1\u03b2","volume":"34","author":"Han","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"R39-20250608","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/PAS.0b013e318247b7bb","article-title":"Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?","volume":"36","author":"Alvarez","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R40-20250608","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/PGP.0000000000000674","article-title":"Equivalent Survival of p53 Mutated Endometrial Endometrioid Carcinoma Grade 3 and Endometrial Serous Carcinoma","volume":"40","author":"Brett","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"R41-20250608","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.20.00549","article-title":"Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy","volume":"38","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J Clin Oncol"},{"key":"R42-20250608","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ygyno.2020.01.029","article-title":"Trends in HPV-dependent and HPV-independent vulvar cancers: the changing face of vulvar squamous cell carcinoma","volume":"157","author":"Eva","year":"2020","journal-title":"Gynecol Oncol"},{"key":"R43-20250608","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"Martel","year":"2020","journal-title":"Lancet Global Health"},{"key":"R44-20250608","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/PGP.0000000000000620","article-title":"HPV-independent vulvar squamous cell carcinoma is associated with significantly worse prognosis compared with HPV-associated tumors","volume":"39","author":"Allo","year":"2020","journal-title":"Int J Gynecol Pathol"},{"key":"R45-20250608","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.humpath.2019.08.003","article-title":"Recurrent genetic alterations and biomarker expression in primary and metastatic squamous cell carcinomas of the vulva","volume":"92","author":"Xing","year":"2019","journal-title":"Hum Pathol"},{"key":"R46-20250608","doi-asserted-by":"crossref","first-page":"8091","DOI":"10.3390\/ijms21218091","article-title":"p53 immunohistochemical patterns in HPV-independent squamous cell carcinomas of the vulva and the associated skin lesions: a study of 779 cases","volume":"21","author":"Rakislova","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R47-20250608","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ygyno.2014.07.094","article-title":"CDKN2A(p16) and HRAS are frequently mutated in vulvar squamous cell carcinoma","volume":"135","author":"Trietsch","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R48-20250608","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ygyno.2018.06.026","article-title":"Somatic mutation profiling of vulvar cancer: exploring therapeutic targets","volume":"150","author":"Zi\u0119ba","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R49-20250608","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00000478-200003000-00013","article-title":"Vulvar intraepithelial neoplasia of the simplex (differentiated) type: a clinicopathologic study including analysis of HPV and p53 expression","volume":"24","author":"Yang","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"R50-20250608","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41379-021-00942-3","article-title":"Molecular landscape of vulvovaginal squamous cell carcinoma: new insights into molecular mechanisms of HPV-associated and HPV-independent squamous cell carcinoma","volume":"35","author":"Salama","year":"2022","journal-title":"Mod Pathol"},{"key":"R51-20250608","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/modpathol.2009.179","article-title":"Differentiated vulvar intraepithelial neoplasia contains Tp53 mutations and is genetically linked to vulvar squamous cell carcinoma","volume":"23","author":"Pinto","year":"2010","journal-title":"Mod Pathol"},{"key":"R52-20250608","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1038\/sj.bjc.6601444","article-title":"TP53 mutations in vulval lichen sclerosus adjacent to squamous cell carcinoma of the vulva","volume":"89","author":"Rolfe","year":"2003","journal-title":"Br J Cancer"},{"key":"R53-20250608","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/s41379-020-0524-1","article-title":"Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status","volume":"33","author":"Tessier-Cloutier","year":"2020","journal-title":"Mod Pathol"},{"key":"R55-20250608","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/PAS.0000000000001778","article-title":"HPV-negative squamous cell carcinomas of the cervix with special focus on intraepithelial precursor lesions","volume":"46","author":"Regauer","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R56-20250608","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s41379-019-0249-1","article-title":"HPV-negative tumors of the uterine cervix","volume":"32","author":"Nicol\u00e1s","year":"2019","journal-title":"Mod Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001970","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T21:02:10Z","timestamp":1749416530000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001970"}},"subtitle":["A Clinicopathologic Analysis With Re-evaluation of Diagnostic Criteria"],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001970","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,5]]}}}